Hunan Jiudian Pharmaceutical Co., Ltd. (300705.SZ)

36.22 +1.21 (+3.46%) At close: 03:04PM CST

Hunan Jiudian Pharmaceutical Co., Ltd.

Building A1, Jinrui Lugu Science and Technology Park
No. 28 Lutian Road Changsha High-tech Development Zone
Changsha 410205
China
86 731 8822 0222
https://www.hnjiudian.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Xia Hui Zheng	General Manager	N/A	N/A	1961
Ms. Ying Xiong	Financial Director	N/A	N/A	1964
Ms. Zhi Yun Zhu	Director of Supply & Director	N/A	N/A	1967
Ms. Lei Zeng	Deputy GM & Secretary of the Board	N/A	N/A	1985
Mr. Ying Liu	Deputy General Manager	N/A	N/A	1975
Mr. Yang Yang	Non-Independent Director & Deputy General Manager	N/A	N/A	1984
Mr. Shang Lu	Employee Representative Supervisor & Director of Production Center	N/A	N/A	1979

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. Its leading products are loxoprofen sodium gel plaster and hydrochloric acid. The company offers its products in the anti-inflammatory and analgesic, anti-infective, anti-allergic, digestive system, cardiovascular and cerebrovascular, gynecological drugs, supplements, and other fields. The company was founded in 2001 and is based in Changsha, China.

Corporate governance

Hunan Jiudian Pharmaceutical Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.